Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Glioblastoma and ATRX[original query] |
|---|
| Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. The oncologist 2017 9 22 (12): 1478-1490. Johnson Adrienne, Severson Eric, Gay Laurie, Vergilio Jo-Anne, Elvin Julia, Suh James, Daniel Sugganth, Covert Mandy, Frampton Garrett M, Hsu Sigmund, Lesser Glenn J, Stogner-Underwood Kimberly, Mott Ryan T, Rush Sarah Z, Stanke Jennifer J, Dahiya Sonika, Sun James, Reddy Prasanth, Chalmers Zachary R, Erlich Rachel, Chudnovsky Yakov, Fabrizio David, Schrock Alexa B, Ali Siraj, Miller Vincent, Stephens Philip J, Ross Jeffrey, Crawford John R, Ramkissoon Shakti |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing. Journal of neuropathology and experimental neurology 2018 Aug 77 (8): 710-716. Cantero Diana, Rodríguez de Lope Ángel, Moreno de la Presa Raquel, Sepúlveda Juan M, Borrás José M, Castresana Javier S, D'Haene Nicky, García Juan F, Salmon Isabelle, Mollejo Manuela, Rey Juan A, Hernández-Laín Aurelio, Meléndez Bárba |
| Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
| IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population. Surgical neurology international 2018 9 29. Chatterjee Debajyoti, Radotra Bishan Dass, Kumar Narendra, Vasishta Rakesh Kumar, Gupta Sunil Kum |
| TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations. Acta neuropathologica communications 2018 10 6 (1): 106. Williams Erik A, Miller Julie J, Tummala Shilpa S, Penson Tristan, Iafrate A John, Juratli Tareq A, Cahill Daniel |
| Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases. Brain pathology (Zurich, Switzerland) 2019 8 30 (2): 235-245. Kwon Mi Jung, Kang So Young, Cho Haeyon, Lee Jung Il, Kim Sung Tae, Suh Yeon-L |
| The importance of IDH1, ATRX and WT-1 mutations in glioblastoma. Polish journal of pathology : official journal of the Polish Society of Pathologists 2020 71 (2): 127-137. Gülten Gülsün, Yalçin NagIhan, Baltalarli Bahar, Dogu Gamze, Acar FerIdun, Dogruel Yüc |
| TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors. Neuro-oncology advances 2020 7 2 (1): vdz059. Cantero Diana, Mollejo Manuela, Sepúlveda Juan M, D'Haene Nicky, Gutiérrez-Guamán Myriam J, Rodríguez de Lope Ángel, Fiaño Concepción, Castresana Javier S, Lebrun Laetitia, Rey Juan A, Salmon Isabelle, Meléndez Bárbara, Hernández-Laín Aurel |
| Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR. Brain sciences 2020 Feb 10 (2): . Salvati Maurizio, Bruzzaniti Placido, Relucenti Michela, Nizzola Mariagrazia, Familiari Pietro, Giugliano Marco, Scafa Anthony Kevin, Galletta Santi, Li Xiaobo, Chen Rui, Barbaranelli Claudio, Frati Alessandro, Santoro Anton |
| Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neuro-oncology advances 2020 12 2 (1): vdaa142. Schulte Jessica D, Buerki Robin A, Lapointe Sarah, Molinaro Annette M, Zhang Yalan, Villanueva-Meyer Javier E, Perry Arie, Phillips Joanna J, Tihan Tarik, Bollen Andrew W, Pekmezci Melike, Butowski Nicholas, Oberheim Bush Nancy Ann, Taylor Jennie W, Chang Susan M, Theodosopoulos Philip, Aghi Manish K, Hervey-Jumper Shawn L, Berger Mitchel S, Solomon David A, Clarke Jennifer |
| Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population. PloS one 2020 11 15 (11): e0242793. Saadeh Fadi S, Morsi Rami Z, El-Kurdi Abdallah, Nemer Georges, Mahfouz Rami, Charafeddine Maya, Khoury Jessica, Najjar Marwan W, Khoueiry Pierre, Assi Hazem |
| TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-oncology advances 2020 11 2 (1): vdaa114. Kikuchi Zensho, Shibahara Ichiyo, Yamaki Tetsu, Yoshioka Ema, Shofuda Tomoko, Ohe Rintaro, Matsuda Ken-Ichiro, Saito Ryuta, Kanamori Masayuki, Kanemura Yonehiro, Kumabe Toshihiro, Tominaga Teiji, Sonoda Yukihi |
| Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital. Scientific reports 2020 10 10 (1): 18445. Egaña Larraitz, Auzmendi-Iriarte Jaione, Andermatten Joaquin, Villanua Jorge, Ruiz Irune, Elua-Pinin Alejandro, Aldaz Paula, Querejeta Arrate, Sarasqueta Cristina, Zubia Felix, Matheu Ander, Samprón Nicol |
| Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
| Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets. Neurological research 2021 7 43 (11): 916-925. Ak Aksoy Secil, Mutlu Melis, Tunca Berrin, Kocaeli Hasan, Taskapilioglu Mevlut Ozgur, Bekar Ahmet, Tekin Cagla, Argadal Omer Gokay, Civan Muhammet Nafi, Kaya ?smail Seckin, Ocak P?nar Eser, Tolunay Sahsi |
| Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas. Acta neuropathologica communications 2021 7 9 (1): 119. Biczok Annamaria, Strübing Felix L, Eder Julia M, Egensperger Rupert, Schnell Oliver, Zausinger Stefan, Neumann Julia E, Herms Jochen, Tonn Joerg-Christian, Dorostkar Mario |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation. Open life sciences 2021 4 16 (1): 323-335. Yuan Hai-Yan, Lv Ya-Juan, Chen Yi, Li Dan, Li Xi, Qu Jian, Yan H |
| Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. The American journal of surgical pathology 2021 2 45 (8): 1082-1090. Eschbacher Kathryn L, Ida Cristiane M, Johnson Derek R, Alvi Mohammed A, Jenkins Sarah M, Ruff Michael W, Kerezoudis Panagiotis, Neth Bryan J, Pasion Romela M, Daniels David J, Kizilbash Sani H, Raghunathan Adit |
| Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma. Anticancer research 2021 12 42 (1): 335-341. Kim Moonsik, Yoo Jihwan, Chang Jong Hee, Kim Se Ho |
| BRAF Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAF . Frontiers in oncology 2021 1 10 531968. Da Rong, Wang Maode, Jiang Haitao, Wang Tuo, Wang W |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Telomerase Reverse Transcriptase Promoter Mutations in A Cohort Of Adult Gliomas - Clinicopathological Correlates. Neurology India 0 70 (3): 953-959. Balakumar Shailaja, Pai Rekha, Chacko Ari G, Patel Bimal, Nancy Rachel, Balakrishnan Rajesh, Sarkar Sauradeep, Sampath Gowri, Chacko Gee |
| H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis. World neurosurgery 2022 6 165 e251-e264. Bin-Alamer Othman, Jimenez Adrian E, Azad Tej D, Bettegowda Chetan, Mukherjee Debr |
| Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
| Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
| Clinical sequencing reveals diagnostic, therapeutic, and prognostic biomarkers for adult-type diffuse gliomas. Heliyon 2024 9 10 (18): e37712. Zhenyan Li, Zhenghao Deng, Fangkun Liu, Chuntao Li, Kui Yang, Xuan Gong, Songshan Feng, Yu Zeng, Hongshu Zhou, Fan Fan, Chengke Luo, Zhixiong Liu, Mingyu Zha |
| Molecular Pathology of Gliomas. Clinics in laboratory medicine 2024 5 44 (2): 149-159. Kristyn Galbraith, Matija Snude |
- Page last reviewed:Feb 1, 2024
- Content source: